
### [NCIT:C3917](http://purl.obolibrary.org/obo/NCIT_C3917)
**Label:** Vaginal Carcinoma

**Subclasses:** [NCIT:C128073](http://purl.obolibrary.org/obo/NCIT_C128073) (Vaginal Neuroendocrine Carcinoma), [NCIT:C7736](http://purl.obolibrary.org/obo/NCIT_C7736) (Vaginal Squamous Cell Carcinoma, Not Otherwise Specified), [NCIT:C128060](http://purl.obolibrary.org/obo/NCIT_C128060) (Vaginal Papillary Carcinoma), [NCIT:C6325](http://purl.obolibrary.org/obo/NCIT_C6325) (Vaginal Verrucous Carcinoma), [NCIT:C8944](http://purl.obolibrary.org/obo/NCIT_C8944) (Vaginal Metastatic Adenocarcinoma), [NCIT:C7735](http://purl.obolibrary.org/obo/NCIT_C7735) (Vaginal Clear Cell Adenocarcinoma), [NCIT:C7860](http://purl.obolibrary.org/obo/NCIT_C7860) (Recurrent Vaginal Carcinoma), [NCIT:C7981](http://purl.obolibrary.org/obo/NCIT_C7981) (Vaginal Adenocarcinoma), [NCIT:C40248](http://purl.obolibrary.org/obo/NCIT_C40248) (Vaginal Warty Carcinoma), [NCIT:C40245](http://purl.obolibrary.org/obo/NCIT_C40245) (Vaginal Basaloid Carcinoma), [NCIT:C40243](http://purl.obolibrary.org/obo/NCIT_C40243) (Vaginal Keratinizing Squamous Cell Carcinoma), [NCIT:C40252](http://purl.obolibrary.org/obo/NCIT_C40252) (Vaginal Mucinous Adenocarcinoma), [NCIT:C40263](http://purl.obolibrary.org/obo/NCIT_C40263) (Vaginal Small Cell Carcinoma), [NCIT:C40264](http://purl.obolibrary.org/obo/NCIT_C40264) (Vaginal Undifferentiated Carcinoma), [NCIT:C40261](http://purl.obolibrary.org/obo/NCIT_C40261) (Vaginal Adenoid Cystic Carcinoma), [NCIT:C40251](http://purl.obolibrary.org/obo/NCIT_C40251) (Vaginal Endometrioid Adenocarcinoma), [NCIT:C40260](http://purl.obolibrary.org/obo/NCIT_C40260) (Vaginal Adenosquamous Carcinoma), [NCIT:C128075](http://purl.obolibrary.org/obo/NCIT_C128075) (Vaginal Large Cell Neuroendocrine Carcinoma), 

**Class expressions from DL-Learner:**

- Thing 52.77%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39135](http://purl.obolibrary.org/obo/NCIT_C39135) (Keratinocyte Differentiation Pathway))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39130](http://purl.obolibrary.org/obo/NCIT_C39130) (Insulin Signaling Pathway))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39128](http://purl.obolibrary.org/obo/NCIT_C39128) (IL7 Signaling Pathway))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39124](http://purl.obolibrary.org/obo/NCIT_C39124) (IL3 Signaling Pathway))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39123](http://purl.obolibrary.org/obo/NCIT_C39123) (IL2RB Pathway))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39121](http://purl.obolibrary.org/obo/NCIT_C39121) (IL22 Signaling Pathway))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39117](http://purl.obolibrary.org/obo/NCIT_C39117) (IL12 Signaling Pathway))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39114](http://purl.obolibrary.org/obo/NCIT_C39114) (IGF-1 Signaling Pathway))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39112](http://purl.obolibrary.org/obo/NCIT_C39112) (IFN Gamma Signaling Pathway))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39103](http://purl.obolibrary.org/obo/NCIT_C39103) (ERBB2 Signaling Pathway))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39102](http://purl.obolibrary.org/obo/NCIT_C39102) (Skeletal Myogenesis Pathway))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39101](http://purl.obolibrary.org/obo/NCIT_C39101) (Human Cytomegalovirus Infection Pathway))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39094](http://purl.obolibrary.org/obo/NCIT_C39094) (Inhibition of Cellular Proliferation by Gleevec Pathway))) 39.52%


